- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2006
- Public Summary Document (PSD) July 2006 PBAC Meeting - PDF
Infliximab – July 2006
Infliximab, powder for I.V. infusion, 100 mg, Remicade®, July 2006
Last updated
27 October 2006
